Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep;20(3):2352-2360.
doi: 10.3892/etm.2020.8961. Epub 2020 Jun 29.

Relationship between chemokines and T lymphocytes in the context of respiratory allergies (Review)

Affiliations
Review

Relationship between chemokines and T lymphocytes in the context of respiratory allergies (Review)

Nicolae Ovidiu Berghi et al. Exp Ther Med. 2020 Sep.

Abstract

Allergic diseases have been classified in the last decades using various theories. The main classes of the newest classification in allergic respiratory diseases focus on the characterization of the endotype (which takes into account biomarkers related to determinant pathophysiological mechanisms) and of the phenotype (based on the description of the disease). Th2, Th1 and Th17 lymphocytes and the type of inflammatory response mediated by them represent the basis for Th2 and non-Th2 endotype classification. In addition, new lymphocytes were also used to characterize allergic diseases: Th9 lymphocytes, Th22 lymphocytes, T follicular helper cells (TFH) lymphocytes and invariant natural killer T (iNKT) lymphocytes. In the last decade, a growing body of evidence focused on chemokines, chemoattractant cytokines, which seems to have an important contribution to the pathogenesis of this pathology. This review presents the interactions between chemokines and Th lymphocytes in the context of Th2/non-Th2 endotype classification of respiratory allergies.

Keywords: asthma; chemokines; endotypes; lymphocytes; respiratory allergies; rhinitis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Interplay between chemokines and T cells. Th1, Th1 lymphocyte; Th2, Th2 lymphocyte; Th9, Th9 lymphocyte; Th17, Th17 lymphocyte; Treg, T regulatory lymphocytes; TFH, T follicular helper cells; iNKT, invariant natural killer T; CCL, C-C motif ligand; CXCL, C-X-C-motif ligand; CCR, C-C receptor.

References

    1. Yii AC, Tay TR, Choo XN, Koh MS, Tee AK, Wang DY. Precision medicine in united airways disease: A ‘treatable traits’ approach. Allergy. 2018;73:1964–1978. doi: 10.1111/all.13496. - DOI - PubMed
    1. Lötvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A, Lemanske RF Jr, Wardlaw AJ, Wenzel SE, Greenberger PA. Asthma endotypes: A new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127:355–360. doi: 10.1016/j.jaci.2010.11.037. - DOI - PubMed
    1. Desai M, Oppenheimer J. Elucidating asthma phenotypes and endotypes: Progress towards personalized medicine. Ann Allergy Asthma Immunol. 2016;116:394–401. doi: 10.1016/j.anai.2015.12.024. - DOI - PubMed
    1. Muraro A, Lemanske RF Jr, Hellings PW, Akdis CA, Bieber T, Casale TB, Jutel M, Ong PY, Poulsen LK, Schmid-Grendelmeier P, et al. Precision medicine in patients with allergic diseases: Airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137:1347–1358. doi: 10.1016/j.jaci.2016.03.010. - DOI - PubMed
    1. Agache I, Akdis CA. Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases. J Clin Invest. 2019;129:1493–1503. doi: 10.1172/JCI124611. - DOI - PMC - PubMed

LinkOut - more resources